Hailey-Hailey disease (HHD), an autosomal dominant disorder resulting from ATP2C1 gene variants, manifests as skin blisters and erosions, typically emerging in the 3rd or 4th decade of life. The absence of a specific therapy underscores the pivotal role of trigger identification and avoidance in HHD management, necessitating lifestyle adjustments such as weight loss and loose clothing. Treatment modalities vary from topical antimicrobials, corticosteroids, and tacrolimus for mild cases to oral antibiotics and emerging therapies like low-dose naltrexone for moderate to severe instances. For mild cases, treatment involves the use of topical antimicrobials, corticosteroids, and tacrolimus. In moderate to severe instances, oral antibiotics are considered, while emerging therapies like low-dose naltrexone show promise but necessitate further investigation. Surgical interventions, botulinum toxin injections, and low-dose naltrexone demonstrate varying success rates; however, HHD remains chronic and recurrent, significantly impacting quality of life. This case report underscores the importance of clinician and patient awareness regarding triggers in HHD management, emphasizing the timeliness of interventions such as antibiotics and corticosteroids. It further highlights the ongoing imperative for effective therapeutic research in Hailey-Hailey diseas